Actinium Pharmaceuticals, Inc. Share Price
Stocks
ATNM
US00507W2061
Biotechnology & Medical Research
|
Market Closed -
NYSE
21:00:00 01/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.9955 USD | -2.40% |
|
-7.82% | -26.80% |
| 08-14 | Actinium Pharmaceuticals Expands Manufacturing Capacity for Actimab-A Program | CI |
| 08-14 | Actinium Pharmaceuticals, Inc. Amends Its Investigational New Drug | CI |
| Market Cap | 31.3M 27M 25.4M 23.14M 43.51M 2.97B 43.74M 300M 117M 1.51B 118M 115M 5.01B | P/E 2026 * |
7.11x | P/E 2027 * | -1.47x |
|---|---|---|---|---|---|
| Enterprise Value | 31.3M 27M 25.4M 23.14M 43.51M 2.97B 43.74M 300M 117M 1.51B 118M 115M 5.01B | EV / Sales 2026 * |
2.68x | EV / Sales 2027 * | - |
| Free-Float |
97.66% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.40% | ||
| 1 week | -7.82% | ||
| Current month | -2.40% | ||
| 1 month | +18.95% | ||
| 3 months | -15.64% | ||
| 6 months | -15.64% | ||
| Current year | -26.80% |
| 1 week | 0.97 |  | 1.05 |
| 1 month | 0.74 | | 1.15 |
| Current year | 0.74 | | 1.53 |
| 1 year | 0.74 | | 1.76 |
| 3 years | 0.74 | | 10.24 |
| 5 years | 0.74 | | 15.12 |
| 10 years | 0.74 | | 64.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sandesh Seth
CEO | Chief Executive Officer | 62 | 08/06/2017 |
Steffen Heeger
CTO | Chief Tech/Sci/R&D Officer | - | 31/05/2026 |
Adeela Kamal
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
C. Nicholson
BRD | Director/Board Member | 71 | 31/12/2007 |
Sandesh Seth
CHM | Chairman | 62 | 30/09/2013 |
| Director/Board Member | 68 | 07/11/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/08/25 | Tax | Chief Executive Officer | 120,900 | 0.3876% | ||
| 31/03/25 | Issuer sale | Chief Financial Officer | 706,588 | 2.2650% | ||
| 31/03/25 | Issuer sale | Chief Executive Officer | 2,385,976 | 7.6484% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.40% | -7.82% | -44.07% | -85.03% | 32.07M | |
| -0.25% | -4.10% | +38.38% | +92.61% | 68.13B | |
| +1.21% | +0.80% | +46.29% | +85.32% | 63.6B | |
| -0.25% | -1.92% | -10.72% | +436.70% | 26.6B | |
| +0.33% | -10.61% | +1.95% | -16.27% | 25.52B | |
| +1.18% | -2.23% | +30.87% | -19.04% | 19.69B | |
| -6.09% | -12.08% | +226.11% | +375.00% | 18.23B | |
| +0.04% | -6.44% | +0.78% | +540.26% | 15.16B | |
| +4.12% | +0.30% | +52.03% | +150.18% | 13.54B | |
| -0.24% | +5.18% | +23.04% | +190.97% | 12.48B | |
| Average | -0.39% | -3.33% | +36.46% | +175.07% | 26.3B | |
| Weighted average by Cap. | +0.02% | -2.95% | +42.04% | +159.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 11.67M 10.06M 9.47M 8.62M 16.22M 1.11B 16.31M 112M 43.56M 563M 43.8M 42.85M 1.87B | - |
| Net income | 4.91M 4.23M 3.98M 3.63M 6.82M 466M 6.86M 47.07M 18.32M 237M 18.42M 18.02M 785M | -31.71M -27.35M -25.73M -23.44M -44.07M -3.01B -44.31M -304M -118M -1.53B -119M -116M -5.08B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/09/26 | US$0.9955 | -2.40% | 30,066 |
| 31/08/26 | US$1.020 | +0.99% | 34,778 |
| 28/08/26 | US$1.010 | +1.00% | 112,015 |
| 27/08/26 | US$1.000 | -0.99% | 92,867 |
| 26/08/26 | US$1.010 | -6.48% | 145,244 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATNM Stock
Select your edition
All financial news and data tailored to specific country editions
